There has been speculation that Boots will sell its over-the-counter medicine business, whose products include Nurofen, Clearasil, Strepsil. Not so, says Rudd. 'It is very profitable and growing. Why would we do anything?' Nor, it seems, is Boots set to bid for Durex and Scholl group SSL, as City rumours suggested earlier this month.